Medical Cannabis: Implications for the Practice of Pharmacy

Wednesday, October 17, 2018 (1:00PM - 2:00PM ET)

*Pre-registration is required to participate.  This live webinar is only available to APhA members*

Activity Preview

As the use for medical cannabis continues to increase combined with the recent FDA approval of cannabidiol for two rare forms of epilepsy, many pharmacists are considering what role they may play in caring for patients who use medical cannabis.

In this webinar, an expert in the field will discuss the potential mechanisms of action of cannabis, various formulations and uses for medical cannabis, patient safety issues including potential drug interactions, and communication strategies for discussing cannabis use with patients. There are many implications medical cannabis could have for the profession of pharmacy, and pharmacists should be equipped to respond to patients considering the use of cannabis.  

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

1. Describe the clinical pharmacology of cannabis and its active components.
2. Evaluate clinical studies that have been performed in patients with various conditions using cannabis.
3. Identify potential drug interactions and other patient safety issues that may occur with the use of cannabis.
4. Discuss communication strategies for talking with patients who are using medical cannabis.

Activity type: Knowledge-based

Target Audience: Pharmacists & Pharmacy Technicians

Learning Level: 2

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-257-L04-P/T. 

To obtain credit for completing Medical Cannabis: Implications for the Practice of Pharmacy, participants will need to complete the 2-step registration process, attend the live webinar, complete the evaluation questions, and then CLAIM credit. An attendance code and detailed instructions on how to claim credit will be provided during the webinar. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

Initial release date: October 17, 2018

Expiration date to claim credit for LIVE webinar: November 19, 2018 

Development

Medical Cannabis: Implications for the Practice of Pharmacy is a live continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.

Disclosures

Laura M. Borgelt, PharmD, FCCP, BCPS, declares receiving honoraria as a speaker from PharmCon, Inc. and as a speaker for MJ for MDs (conference).   

APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures. 

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, MBA, Associate Director of Content Development at the American Pharmacists Association. 

Fee

There is no fee associated with this member only activity. 

*This webinar will be archived and made available as an online learning activity within 1 week after the live offering has been presented. The archived webinar (home-study version) will be available to APhA members ONLY, as a free member benefit, during the first 30 days after release. Thereafter, nonmembers can purchase the archived webinar at a cost of $129.*